77 results
424B3
DMAC
DiaMedica Therapeutics Inc.
18 Jul 24
Prospectus supplement
5:28pm
at the meeting of shareholders. The affirmative vote of a simple majority of the votes cast is required to pass an ordinary resolution at a meeting … the chairman of the Board of Directors, the chief executive officer, or president in the absence of a chief executive officer, or a majority
8-K
EX-10.2
DMAC
DiaMedica Therapeutics Inc.
26 Jun 24
DiaMedica Therapeutics Announces $11.8 Million
8:16am
the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that the Company is notified of such objection
8-K
EX-10.1
DMAC
DiaMedica Therapeutics Inc.
23 May 24
Departure of Directors or Certain Officers
4:00pm
. The Committee will act by majority approval of the members at a meeting or by unanimous written consent, and a majority of the members of the Committee
8-K
EX-99.1
j1r1os2j5c sqt1h84
8 May 24
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2024 Financial Results
4:30pm
8-K
EX-99.1
0edaqveeoxhmdhsy9wp6
19 Mar 24
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
4:16pm
424B3
fpvobo du3
10 Jul 23
Prospectus supplement
4:16pm
8-K
EX-10.2
r8tnn 1ea71nyc
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am
8-K
EX-3.1
8tvvrsi7vxzk
18 May 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-10.1
vr0b68mj 7mroth6ul12
19 May 22
Departure of Directors or Certain Officers
5:00pm